Colchicine

🧮 Dose calculator

Gout · Regimen source: FDA Colcrys · 2.1

• • At the first sign of a flare. Not recommended in patients on prophylactic dose plus CYP3A4 inhibitors. FDA Colcrys · 2.1FDA Colcrys · 2.4

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Colcrys · 8.1

  “Pregnancy Category C.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Colcrys · 8.3

  “Caution should be exercised, and breastfeeding infants should be observed for adverse effects when COLCRYS is administered to a nursing woman.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Colcrys · 8.4

  “Gout is rare in pediatric patients; safety and effectiveness of colchicine in pediatric patients has not been established.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Colcrys · 8.5

  “In general, dose selection for an elderly patient with gout should be cautious, reflecting the greater frequency of decreased renal function, concomitant disease or other drug therapy [see Dose Modification for Coadministration of Interacting Drugs (2.4) and Pharmacokinetics (12.3) ] .”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.